Drugs that contain Cinacalcet Hydrochloride

1. List of Sensipar drug patents

SENSIPAR's oppositions filed in EPO
SENSIPAR Litigations
Patent Number Company Patent Title Patent Expiry Activity Alert
These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US7829595 AMGEN Rapid dissolution formulation of a calcium receptor-active compound
Sep, 2026

(3 years from now)

US9375405 AMGEN Rapid dissolution formulation of a calcium receptor-active compound
Sep, 2026

(3 years from now)

Market Authorisation Date: 08 March, 2004

Treatment: Method of treating hyperparathyroidism; Method of treating hypercalcemia

Dosage: TABLET;ORAL

How can I launch a generic of SENSIPAR before it's patent expiration?
More Information on Dosage

SENSIPAR family patents

11

United States

8

European Union

7

Spain

6

Denmark

6

Slovenia

6

Portugal

6

Poland

5

Hungary

4

Turkey

3

Japan

2

Brazil

2

Cyprus

1

Israel

1

South Africa

1

Mexico

1

Australia

1

Norway

1

Germany

1

Singapore

1

Argentina

1

Croatia

1

Malaysia

1

Korea, Republic of

1

Iceland

1

Taiwan, Province of China

1

China

EA

1

EA

1

Canada

1

New Zealand

900+ leading pharmaceutical companies are staying up-to-date with drug patents through Pharsight

Join them to stay ahead in capturing the next drug going generic

Other things you might be interested in